Castle Biosciences, Inc. CSTL
$35.18
$1.745.20%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.06M | -14.52M | -2.33M | -501.00K | 4.52M |
| Total Depreciation and Amortization | 4.07M | 3.93M | 3.78M | -16.28M | 23.51M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.06M | 7.82M | 11.52M | 27.91M | -15.73M |
| Change in Net Operating Assets | 1.13M | -19.36M | 13.97M | 11.50M | 8.51M |
| Cash from Operations | 15.20M | -22.13M | 26.93M | 22.63M | 20.82M |
| Capital Expenditure | -8.65M | -12.46M | -7.18M | -14.83M | -9.26M |
| Sale of Property, Plant, and Equipment | 6.00K | 7.00K | 5.00K | 19.00K | 12.00K |
| Cash Acquisitions | -- | -- | -1.00K | 0.00 | -18.73M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -7.32M | -13.36M | 16.01M | -3.57M | -401.00K |
| Cash from Investing | -15.96M | -25.80M | 8.83M | -18.39M | -28.38M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -24.00K | -24.00K | -27.00K | -31.00K | -31.00K |
| Issuance of Common Stock | 931.00K | 1.59M | 2.81M | 297.00K | 531.00K |
| Repurchase of Common Stock | -793.00K | -6.60M | -7.37M | -1.19M | -589.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.00M | -- | 0.00 | 0.00 | 190.00K |
| Cash from Financing | -886.00K | -5.03M | -4.59M | -919.00K | 101.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.65M | -52.97M | 31.17M | 3.32M | -7.46M |